#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombocytosis Endocrine ophthalmopathy Acquired haemophilia Subdural haematoma Cholangiosarcoma Small for dates baby Paget's disease of the vulva Infertility female Von Hippel-Lindau disease Cerebellar ataxia Soft tissue necrosis Ovarian epithelial cancer Chemical burn Gastrooesophageal cancer Hyperphagia More trials…

    Learn about Rare Diseases

    Osteosarcoma KBG syndrome – Diagnostics Hairy cell leukaemia recurrent – Life with Disease Progressive supranuclear palsy – Basic Information Toxic epidermal necrolysis – Life with Disease Kearns-Sayre syndrome – Trials in Disease Crigler-Najjar syndrome – Treatment Hereditary ataxia – Diagnostics Hepatoblastoma – Trials in Disease Glycogen storage disease type V – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vepdegestrant Aspergillus Fumigatus Human Immunoglobulin G Colesevelam 177LU-FAP-2286 Promethazine Hydrochloride Sodium Hydrogen Carbonate Felis Domesticus (555) Cellulose, Microcrystalline Cyclophosphamide Ceftolozane Iptacopan Sotagliflozin Tozorakimab Octreotide Canakinumab Azd0305 Sabestomig Lysine Acetate Bimekizumab More therapies…

    Learn about Your Condition

    Rasmussen encephalitis Infantile spasms Placenta praevia Triple positive breast cancer Aphthous ulcer Hypertrophic cardiomyopathy Nephroblastoma Renal injury Synovitis Antisynthetase syndrome Drug dependence BK virus infection Congenital myopathy Cardiac valve disease Ligament sprain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure

  • Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia France Germany Greece Poland +1

  • Study on Manganese Uptake in Heart Failure Patients Using Mangafodipir Trisodium and Gadoteric Acid

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • ANHYDROUS MANGAFODIPIR TRISODIUM
    • Gadoteric Acid
    Norway

  • Study on Dapagliflozin for Heart Failure Patients After a Heart Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Dapagliflozin
    France

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Captopril
    • Cilazapril
    • Enalapril Maleate
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Left ventricular dysfunction
    • Cardiac failure
    Investigated Drugs:
    • Vericiguat
    Belgium Denmark Finland France Germany Hungary +7

  • Study on Empagliflozin’s Effect on Heart Function in Non-Diabetic Pre-Heart Failure Patients Using Fitbit and mHealth for Exercise Guidance

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Empagliflozin
    Ireland
Previous Page
1 … 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!